hotspot -WSS

hotspot

author：Wikipedia 2025-08-12 11:30:04 - browse：6171

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： David Sabatini, ex

WSS

Adam's Biotech Scorecard: Do Sarepta's exon

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

A virus, fished out of a lake, may have saved a man’s life

Startling documents reveal new facets of Sacklers' opioid empire

Lab trade group sues FDA to halt regulation of lab

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Wikipedia

hotspot

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Affirmative action in medical school literally saved lives

Bristol 'take

What does generative AI mean for health care? We asked experts

First Opinion Podcast: What happens when kids become caregivers?

Peter Hotez and the public health issue of online harassment

Biohaven protein

Medical leaders decry Supreme Court decision on affirmative action

Why Charlie Gard's case is so disturbing to Americans

focus

Chan Zuckerberg Biohub Chicago to focus on inflammation

Why age limits for politicians are a terrible idea

Why Charlie Gard's case is so disturbing to Americans

A virus, fished out of a lake, may have saved a man’s life

What to expect at HLTH 2023, the health care industry conference

AI can decode, harness the power of the humane immune system

entertainment

entertainment

hotspot

explore